The Sixth George Swanson Christie Memorial Lecture: Growth factors and their receptors: New opportunities for cancer treatment

References

• Nicolson GL. Paracrine/autocrine growth mechanisms in tumor metastasis. Oncol Res 1992; 4: 389–399
   PubMed Web of Science ®Google Scholar
• LeJeune, S, Leek, R, Horak, E, et al. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res 1993; 53: 3597–3602
   PubMed Web of Science ®Google Scholar
• Culouscou, J-M, Ramacle-Bonnet, M, Carlton, W, et al. Colorectum cell-derived growth factor (CRDGF) is homologous to Amphiregulin, a member of the epidermal growth factor family. Growth Factors 1992; 7: 195–205
   PubMed Web of Science ®Google Scholar
• Ziober, BL, Willson, JK, Hymphrey, LE, et al. Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. J Biol Chem 1993; 268: 691–698
   PubMed Web of Science ®Google Scholar
• Sizeland AM, Burgess AW. Anti-sense transforming growth factor α oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. Mol Cell Biol 1992; 3: 1235–1243
   Web of Science ®Google Scholar
• Ciardiello, F, Bianco, C, Normanno, N, et al. Infection with a transforming growth factor alpha anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line. Int J Cancer 1993; 54: 952–958
   PubMed Web of Science ®Google Scholar
• Noguchi, S, Motomura, K, Inaji, H, et al. Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer. Cancer 1993; 72: 131–136
   PubMed Web of Science ®Google Scholar
• Fleming, TP, Saxena, A, Clark, WC, et al. Amplification and/or over-expression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 1992; 52: 4550–4553
   PubMed Web of Science ®Google Scholar
• Ekstrand, AJ, Sugawa, N, James, CD, et al. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 1992; 89: 4309–4313
   PubMed Web of Science ®Google Scholar
• Torp, SH, Helseth, E, Ryan, L, et al. Expression of the epidermal growth factor receptor gene in human brain metastases. APMIS 1992; 100: 713–719
   PubMed Web of Science ®Google Scholar
• Hermanson, M, Funa, K, Hartman, M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52: 3213–3219
   PubMed Web of Science ®Google Scholar
• Yonemura, Y, Takamura, H, Ninomiya, I, et al. Interrelationship between transforming growth factor receptor-α and epidermal growth factor in advanced gastric cancer. Oncology 1992; 49: 157–161
   PubMed Web of Science ®Google Scholar
• Karnes, WE, Walsh, JH, Wu, SV, et al. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptors. Gastroenterology 1992; 102: 474–485
   PubMed Web of Science ®Google Scholar
• Imyanitov, EN, Chernitsa, OI, Serova, OM, et al. Amplification of HER-2 (erB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients. Neoplasma 1993; 40: 35–39
   PubMed Web of Science ®Google Scholar
• Duda, RB, Cundiff, D, August, CZ, et al. Growth factor receptor and related oncogene determination in mesenchymal tumors. Cancer 1993; 714: 3526–3530
   Web of Science ®Google Scholar
• Hynes NE. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 1993; 4: 19–26
   PubMed Web of Science ®Google Scholar
• Stancovski, I, Peles, E, Ben-Levy, R, et al. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy. J Steroid Biochem Mol Biol 1992; 43: 95–103
   PubMed Web of Science ®Google Scholar
• Zhau, HE, Wan, DS, Zhou, J, et al. Expression of c-erb-β/neu protooncogene in human prostatic cancer tissues and cell lines. Molec Carcinog 1992; 5: 320–327
   PubMed Web of Science ®Google Scholar
• Kasprzyk, PG, Song, SU, Di Fiore, PP, et al. Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies. Cancer Res 1992; 52: 2771–2776
   PubMed Web of Science ®Google Scholar
• Bacus, SS, Stancovski, I, Huberman, E, et al. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res 1992; 52: 2580–2589
   PubMed Web of Science ®Google Scholar
• Lemoine, NR, Lobresco, M, Leung, H, et al. The erbB-3 gene in human pancreatic cancer. J Pathol 1992; 168: 269–273
   PubMed Web of Science ®Google Scholar
• Lemoine, NR, Barnes, DM, Hollywood, DP, et al. Expression of the ERBB3 gene product in breast cancer. Br J Cancer 1992; 66: 1116–1121
   PubMed Web of Science ®Google Scholar
• Yang, KP, Samaan, NA, Liang, YF, et al. Role of insulin-like growth factor-I in the autocrine regulation of cell growth in TT human medullary thyroid carcinoma cells. Henry Ford Hospt Med J 1992; 40: 293–295
   PubMedGoogle Scholar
• Arteaga CL. Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res Treat 1992; 22: 101–106
   PubMed Web of Science ®Google Scholar
• Cullen, KJ, Lippman, ME, Chow, D, et al. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 1992; 6: 91–100
   PubMedGoogle Scholar
• Reiss, K, Ferber, A, Travali, S, et al. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. Cancer Res 1991; 51: 5997–6000
   PubMed Web of Science ®Google Scholar
• Waterfield, MD, Scrace, GT, Whittle, N, et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 1983; 304: 35–39
   PubMed Web of Science ®Google Scholar
• Doolittle, RF, Hunkapillar, MW, Hood, LE, et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 1983; 221: 275–277
   PubMed Web of Science ®Google Scholar
• Vassbotn, FS, Andersson, M, Westermark, B, et al. Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant. Mol Cell Biol 1993; 13: 4066–4076
   PubMed Web of Science ®Google Scholar
• Kypta, RM, Goldberg, Y, Ulag, ET, et al. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990; 62: 481–492
   PubMed Web of Science ®Google Scholar
• Wilson LK, Parsons SJ. Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. Oncogene 1990; 5: 1471–1480
   PubMed Web of Science ®Google Scholar
• Twanley-Stein, GM, Pepperkok, R, Ansorge, W, et al. The Src family tyrosine kinases are required for platelet-derived growth factormediated signal transduction in NIH 3T3 cells. Proc Natl Acad Sci USA 1993; 90: 7696–7700
   PubMed Web of Science ®Google Scholar
• Kizaka-Kondoh, S, Sato, K, Tamura, K, et al. Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. Mol Cell Biol 1992; 12: 5078–5086
   PubMed Web of Science ®Google Scholar
• App, H, Hazan, R, Zilberstein, A, et al. Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor. Mol Cell Biol 1991; 11: 913–919
   PubMed Web of Science ®Google Scholar
• Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 1993; 90: 5889–5892
   PubMed Web of Science ®Google Scholar
• Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Reg 1991; 2: 965–978
   PubMedGoogle Scholar
• Parker PJ, Waterfield MD. Phosphatidylinositol 3-kinase: a novel effector. Cell Growth Diff 1992; 3: 747–752
   PubMedGoogle Scholar
• Rhee SG. Inositol phospholipid-specific phospholipase C: interaction of the γ1 isoform with tyrosine kinase. TIBS 1991; 16: 297–301
   PubMed Web of Science ®Google Scholar
• Satoh, T, Endo, M, Nakafuku, M, et al. Platelet-derived growth factor stimulates formation of active p21rasGTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 1990; 87: 5993–5997
   PubMed Web of Science ®Google Scholar
• Satoh, T, Endo, M, Nakafuku, M, et al. Accumulation of p21rasGTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci USA 1990; 87: 7926–7929
   PubMed Web of Science ®Google Scholar
• Gibbs, JB, Marshall, MS, Scolnick, EM, et al. Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J Biol Chem 1990; 265: 20437–20442
   PubMed Web of Science ®Google Scholar
• Mulcahy LS, Smith MR, Stacey DW. Requirement for ras protooncogene function during serum-stimulated growth of NIH3T3 cells. Nature 1985; 313: 241–243
   PubMed Web of Science ®Google Scholar
• Feig LA, Cooper GM. Inhibition of NIH 3T3 proliferation by a mutant ras protein with preferential affinity for GDP. Moll Cell Biol 1988; 8: 3235–3243
   PubMed Web of Science ®Google Scholar
• Stacey DW, Feig LA, Gibbs JB. Dominant inhibitory ras mutants selectively inhibit the activity of either cellular or oncogenic ras. Mol Cell Biol 1991; 11: 4053–4064
   PubMed Web of Science ®Google Scholar
• Medema RH, Wubbolts R, Bos JL. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol Cell Biol 1991; 11: 5963–5967
   PubMed Web of Science ®Google Scholar
• Cai H, Szeberenyi J, Cooper GM. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol Cell Biol 1990; 10: 5314–5323
   PubMed Web of Science ®Google Scholar
• Thomas, SM, DeMarco, M, D'Arcangelo, G, et al. Ras is essential for nerve growth factor — and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 1992; 68: 1031–1040
   PubMed Web of Science ®Google Scholar
• Wood, KW, Sarnecki, C, Roberts, TM, et al. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 1992; 68: 1041–1050
   PubMed Web of Science ®Google Scholar
• Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62: 851–891
   PubMed Web of Science ®Google Scholar
• Willumsen, BM, Norris, K, Papageorge, AG, et al. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J 1984; 3: 2581–2585
   PubMed Web of Science ®Google Scholar
• Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Downward J. Regulatory mechanisms for ras proteins. BioEssays 1992; 14: 177–184
   PubMed Web of Science ®Google Scholar
• Bowtell, D, Fu, P, Simon, M, et al. Identification of murine homologues of the Drosophila Son of sevenless gene: potential activators of ras. Proc Natl Acad Sci USA 1992; 89: 6511–6515
   PubMed Web of Science ®Google Scholar
• Cen, H, Papageorge, AG, Zippel, R, et al. Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24. EMBO J 1992; 11: 4007–4015
   PubMed Web of Science ®Google Scholar
• Shou, C, Farnsworth, CL, Neel, BG, et al. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for ras. Nature 1992; 358: 351–354
   PubMed Web of Science ®Google Scholar
• Kaibuchi, K, Mizuno, T, Fujioka, H, et al. Molecular cloning of the cDNA for stimulatory GDP/GTP exchange protein for smg p21s (ras p21-like small GTP binding proteins) and characterization of stimulatory GDP/GTP exchange protein. Mol Cell Biol 1991; 11: 2873–2880
   PubMed Web of Science ®Google Scholar
• Downward, J, Graves, JD, Warne, PH, et al. Stimulation of p21ras upon T-cell activation. Nature 1990; 346: 719–723
   PubMed Web of Science ®Google Scholar
• Buday L, Downward J. Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts. Mol Cell Biol 1993; 13: 1903–1910
   PubMed Web of Science ®Google Scholar
• Nanberg E, Westermark B. Platelet-derived growth factor increases the turnover of GTP/GDP on ras in permeabilized fibroblasts. J Biol Chem 1993; 268: 18187–18194
   PubMed Web of Science ®Google Scholar
• Li, B-Q, Kaplan, D, Kung, H, et al. Nerve growth factor stimulation of the ras-guanine nucleotide exchange factor and GAP activities. Science 1992; 256: 1456–1459
   PubMed Web of Science ®Google Scholar
• Ellis, C, Moran, M, McCormick, G, et al. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 1990; 343: 377–381
   PubMed Web of Science ®Google Scholar
• Kaplan, DR, Morrison, DK, Wong, G, et al. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 1990; 61: 125–130
   PubMed Web of Science ®Google Scholar
• Liu X, Pawson T. The epidermal growth factor receptor phosphorylates GTPase-activating protein (GAP) at Tyr-460, adjacent to the GAP SH2 domains. Mol Cell Biol 1991; 11: 2511–2516
   PubMed Web of Science ®Google Scholar
• Serth, J, Weber, W, Frech, M, et al. Binding of the H-ras GTPase activating protein by the activated epidermal growth factor receptor leads to inhibition of the p21 GTPase activity in vitro. Biochemistry 1992; 31: 6361–6365
   PubMed Web of Science ®Google Scholar
• Anderson, D, Koch, CA, Grey, L, et al. Binding of SH2 domains of phospholipase Cγ1, GAP, and Src to activated growth factor receptors. Science 1990; 250: 979–982
   PubMed Web of Science ®Google Scholar
• Moran, MF, Koch, CA, Anderson, D, et al. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 1990; 87: 8622–8626
   PubMed Web of Science ®Google Scholar
• Pawson T, Gish GD. SH2 and SH3 domains: from structure to function. Cell 1992; 71: 359–362
   PubMed Web of Science ®Google Scholar
• Songyang, Z, Shoelson, SE, Chaudhuri, M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993; 72: 767–778
   PubMed Web of Science ®Google Scholar
• Moran, MF, Polakis, P, McCormick, F, et al. Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein. Mol Cell Biol 1991; 11: 1804–1812
   PubMed Web of Science ®Google Scholar
• Adari, H, Lowy, DR, Willumsen, BM, et al. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 1988; 240: 518–521
   PubMed Web of Science ®Google Scholar
• Calés, C, Hancock, JF, Marshall, CJ, et al. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature 1988; 332: 548–550
   PubMed Web of Science ®Google Scholar
• McCormick F. ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989; 56: 5–8
   PubMed Web of Science ®Google Scholar
• Stone JC, Colleton M, Bottorff D. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction. Mol Cell Biol 1993; 13: 7311–7320
   PubMed Web of Science ®Google Scholar
• Vogel, US, Dixon, RAF, Schaber, MD, et al. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 1988; 335: 90–93
   PubMed Web of Science ®Google Scholar
• Daston, MM, Scrable, H, Norlund, M, et al. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann Cells, and oligodendrocytes. Neuron 1992; 8: 415–428
   PubMed Web of Science ®Google Scholar
• Golubic, M, Roudebush, M, Dobrowolski, S, et al. Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 1992; 7: 2151–2159
   PubMed Web of Science ®Google Scholar
• Xu, G, Lin, B, Tanaka, K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990; 63: 835–841
   PubMed Web of Science ®Google Scholar
• Martin, GA, Viskochil, D, Bollag, G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990; 63: 843–849
   PubMed Web of Science ®Google Scholar
• Wallace, MR, Marchuk, DA, Andersen, LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249: 181–186
   PubMed Web of Science ®Google Scholar
• Basu, TN, Gutmann, DH, Fletcher, JA, et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 fibromatosis patients. Nature 1992; 356: 713–715
   PubMed Web of Science ®Google Scholar
• DeClue, JE, Papageorge, AG, Fletcher, JA, et al. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (Type 1) neurofibromatosis. Cell 1992; 69: 265–273
   PubMed Web of Science ®Google Scholar
• Chardin, P, Camonis, JH, Gale, NW, et al. Human Sos 1: a guanine nucleotide exchange factor for ras that binds to GRB2. Science 1993; 260: 1338–1343
   PubMed Web of Science ®Google Scholar
• Clark SG, Stern MJ, Horvitz HR. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 1992; 356: 340–344
   PubMed Web of Science ®Google Scholar
• Lowenstein, EJ, Daly, RJ, Batzer, AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992; 70: 431–442
   PubMed Web of Science ®Google Scholar
• Ren, R, Mayer, BJ, Cicchetti, P, et al. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993; 259: 1157–1161
   PubMed Web of Science ®Google Scholar
• Egan, SE, Giddings, BW, Brooks, MW, et al. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 45–51
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock, M, Fernley, R, Wade, J, et al. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 1993; 363: 83–85
   PubMed Web of Science ®Google Scholar
• Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adaptor protein, and Sos nucleotide exchange factor. Cell 1993; 73: 611–620
   PubMed Web of Science ®Google Scholar
• Li, N, Batzer, A, Daly, R, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 1993; 363: 85–88
   PubMed Web of Science ®Google Scholar
• Pelicci, G, Lanfrancone, L, Grignani, F, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70: 93–104
   PubMed Web of Science ®Google Scholar
• Ruff-Jamison, S, McGlade, J, Pawson, T, et al. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. J Biol Chem 1993; 268: 7610–7612
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock, M, McGlade, J, Mbamalu, G, et al. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360: 689–692
   PubMed Web of Science ®Google Scholar
• McGlade, J, Cheng, A, Pelicci, G, et al. She proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc Natl Acad Sci USA 1992; 89: 8869–8873
   PubMed Web of Science ®Google Scholar
• Ravichandran, KS, Lee, KK, Songyang, Z, et al. Interaction of She with the ∝ chain of the T cell receptor upon T cell activation. Science 1993; 262: 902–905
   PubMed Web of Science ®Google Scholar
• Gale, NW, Kaplan, S, Lowenstein, EJ, et al. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993; 363: 88–92
   PubMed Web of Science ®Google Scholar
• Cen, H, Papageorge, AG, Vass, WC, et al. Regulated and constitutive activity by CDC25Mm (GRF), a ras-specific exchange factor. Mol Cell Biol 1993; 13: 7118–7124
   Web of Science ®Google Scholar
• Barlat, I, Schweighoffer, F, Cevallier-Multon, MC, et al. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells. Oncogene 1993; 8: 215–218
   PubMed Web of Science ®Google Scholar
• Stacey, DW, Roudebush, M, Day, R, et al. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 1991; 6: 2297–2304
   PubMed Web of Science ®Google Scholar
• Kolch, W, Heidecker, G, Lloyd, P, et al. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 1991; 349: 426–428
   PubMed Web of Science ®Google Scholar
• Schaap, D, van der Wal, J, Howe, LR, et al. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem 1993; 268: 20232–20236
   PubMed Web of Science ®Google Scholar
• Rapp UR. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 1991; 6: 495–500
   PubMed Web of Science ®Google Scholar
• Rapp, UR, Goldsbrough, MD, Mark, GE, et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci USA 1983; 80: 4218–4222
   PubMed Web of Science ®Google Scholar
• Moodie, SA, Willumsen, BM, Weber, MJ, et al. Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 1993; 260: 1658–1661
   PubMed Web of Science ®Google Scholar
• Vojtek AB, Hollenberg SM, Cooper JA. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 1993; 74: 205–214
   PubMed Web of Science ®Google Scholar
• Zhang, X, Settleman, J, Kyriakis, JM, et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993; 364: 308–313
   PubMed Web of Science ®Google Scholar
• Warne PH, Viciana PR, Downward J. Direct interaction of ras and the amino-terminal region of Raf-1 in vitro. Nature 1993; 364: 352–355
   PubMed Web of Science ®Google Scholar
• Van Aelst, L, Barr, M, Marcus, S, et al. Complex formation between RAS and RAF and other protein kinases. Proc Natl Acad Sci USA 1993; 90: 6213–6217
   PubMed Web of Science ®Google Scholar
• Howe, LR, Leevers, SJ, Gómez, N, et al. Activation of the MAP kinase pathway by the protein kinase raf. Cell 1992; 71: 335–342
   PubMed Web of Science ®Google Scholar
• Huang, W, Alessandrini, A, Crews, CM, et al. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Proc Natl Acad Sci USA 1993; 90: 10947–10951
   PubMed Web of Science ®Google Scholar
• Campos-González R, Glenney J, Jr. Tyrosine phosphorylation of mitogen-activated protein kinase in cells with tyrosine kinasenegative epidermal growth factor receptors. J Biol Chem 1992; 267: 14535–14538
   PubMed Web of Science ®Google Scholar
• Baselga, J, Norton, L, Masui, H, et al. Antitumor effect of Doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993; 85: 1327–1332
   PubMed Web of Science ®Google Scholar
• Nur-E-Kamal MSA, Varga M, Maruta H. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. J Biol Chem 1993; 268: 22331–22337
   PubMed Web of Science ®Google Scholar
• Duchesne, M, Schweighoffer, F, Parker, F, et al. Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. Science 1993; 259: 525–528
   PubMed Web of Science ®Google Scholar
• Kitayama, H, Sugimoto, Y, Matsuzaki, T, et al. A ras-related gene with transformation suppressor activity. Cell 1989; 57: 77–84
   Web of Science ®Google Scholar
• Hata, Y, Kikuchi, A, Sasaki, T, et al. Inhibition of the ras p21 GTPase-activating protein-stimulated GTPase activity of c-Ha-ras p21 by smg p21 having the same putative effector domain as ras p21s. J Biol Chem 1990; 265: 7104–7107
   PubMed Web of Science ®Google Scholar
• French, M, John, J, Pizon, V, et al. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science 1990; 249: 169–171
   PubMed Web of Science ®Google Scholar
• Zhang, K, Noda, M, Vass, WC, et al. Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1. Science 1990; 249: 162–165
   PubMed Web of Science ®Google Scholar
• Kitayama, H, Matsuzaki, T, Ikawa, Y, et al. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations. Proc Natl Acad Sci USA 1990; 87: 4284–4288
   PubMed Web of Science ®Google Scholar
• Hancock, JF, Magee, AI, Childs, JE, et al. All ras proteins are polyisoprenylated but only sone are palmitoylated. Cell 1989; 57: 1167–1177
   PubMed Web of Science ®Google Scholar
• Schaber, MD, O'Hara, MB, Garsky, VM, et al. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase. J Biol Chem 1990; 265: 14701–14704
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. Mad bet for rab. Nature 1993; 366: 14–15
   PubMed Web of Science ®Google Scholar
• Cox AD, Der CJ. The ras/cholesterol connection: implications for ras oncogenicity. Crit Rev Oncog 1992; 3: 365–400
   PubMedGoogle Scholar
• Schafer, WR, Kim, R, Sterne, R, et al. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science 1989; 245: 379–385
   PubMed Web of Science ®Google Scholar
• Ruch, RJ, Madhukar, BV, Trosko, JE, et al. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Mol Carcinog 1993; 7: 50–59
   PubMed Web of Science ®Google Scholar
• Doyle JW, Kandutsch AA. Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J Cell Physiol 1988; 137: 133–140
   PubMed Web of Science ®Google Scholar
• DeClue, JE, Vass, WC, Papageorge, AG, et al. Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res 1991; 51: 712–717
   PubMed Web of Science ®Google Scholar
• Gibbs, JB, Pompliano, DL, Mosser, SD, et al. Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J Biol Chem 1993; 268: 7617–7620
   PubMed Web of Science ®Google Scholar
• Goldstein, JL, Brown, MS, Stradley, SJ, et al. Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase. J Biol Chem 1991; 266: 15575–15578
   PubMed Web of Science ®Google Scholar
• Kohl, NE, Mosser, SD, DeSolms, SJ, et al. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 1993; 260: 1934–1937
   PubMed Web of Science ®Google Scholar
• James, GL, Goldstein, JL, Brown, MS, et al. Benzodiazepine peptidomimetics: potent inhibitors of ras farnesylation in animal cells. Science 1993; 260: 1937–1942
   PubMed Web of Science ®Google Scholar
• Garcia, AN, Rowell, C, Ackermann, K, et al. Peptidomimetic inhibitors of ras farnesylation and function in whole cells. J Biol Chem 1993; 268: 18415–18418
   PubMed Web of Science ®Google Scholar
• Liu, WC, Barbacid, M, Bulgar, M, et al. 10′-desmetoxystreptonigrin, a novel analog of streptonigrin. J Antibiotics 1992; 45: 454–457
   PubMed Web of Science ®Google Scholar
• Van Der Pyl, D, Inokoshi, J, Shiomi, K, et al. Inhibition of farnesylprotein transferase by gliotoxin and acetylgliotoxin. J Antibiotics 1992; 45: 1802–1805
   PubMed Web of Science ®Google Scholar
• Omura, S, Van Der Pyl, D, Inokoshi, J, et al. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actiymycete. J Antibiotics 1993; 46: 222–235
   PubMed Web of Science ®Google Scholar
• Miura S, Hasumi K, Endo A. Inhibition of protein prenylation by patulin. FEBS Letter 1993; 318: 88–90
   PubMed Web of Science ®Google Scholar
• Hara, M, Akasaka, K, Akinaga, S, et al. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA 1993; 90: 2281–2285
   PubMed Web of Science ®Google Scholar